NEK9 and pachyonychia congenita: Overall survival analyses show that the expression of BUB1, CDK1, MET, PAK1, PRKCI, RIPK2, NEK2, FGFR1, NEK9 were significantly correlated with the prognosis of PC patients (Table 1).